Real-world data confirms utility of EsoGuard as a non-invasive triage tool to significantly increase positive yield of invasive upper endoscopy NEW YORK, Aug. 6, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the release of new real-world data from its ENVET-BE study supporting the clinical utility of the EsoGuard® Esophageal DNA test as a no ...

HORSHAM, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, and Christopher Lesovitz, Chief Financial Officer, will participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference being held on August 12 – 13, 2 ...

- Announced positive outcomes from the C-GUARDIANS IDE clinical trial of the CGuard™ Prime carotid stent system demonstrating a one-year primary endpoint event rate of 1.95%, the lowest for any carotid stent or embolic protection device pivotal trial – - On track to submit a Premarket Approval (PMA) application to the FDA this quarter - - Raised gross proceeds of $17.9 million from full exercise of Series H warrants triggered by announcement of C-GUARDIANS data - -- Management to host investor conference ca ...

201 Blocks Won in July, 27% Increase M/M BTC Production of 692 BTC, 17% Increase M/M Increased BTC Holdings to 20,818 BTC; Total Cash and BTC of $1.6B as of July 31, 2024 Fort Lauderdale, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- MARA (NASDAQ: MARA) ("MARA" or the "Company"), one of the world's largest publicly traded bitcoin ("BTC") miners and a leader in supporting and securing the Bitcoin ecosystem, today published unaudited BTC production and miner installation updates for July 2024. Management Commentary " ...

DALLAS, Aug. 6, 2024 /PRNewswire/ -- Oncor Electric Delivery Company LLC ("Oncor") today reported three months ended June 30, 2024 net income of $251 million compared to three months ended June 30, 2023 net income of $200 million. The $51 million increase was driven by higher revenues primarily due to updated interim rates to reflect increases in invested capital, increases in transmission billing units, higher customer consumption primarily attributable to weather, the new base rates implemented in May 202 ...

文章核心观点 - 公司与大众汽车金融服务公司(VWFS)建立合作关系,利用数据和人工智能技术提升客户和员工体验,优化流程,增强行业竞争力[2][3][4][5] - 公司将在VWFS的业务中部署多种人工智能解决方案,包括提高客户服务和运营效率的工具[4][6] - 这些解决方案将提升员工绩效,缩短文书处理时间,主动满足客户需求,改善VWFS的整体客户体验[6] 行业总结 - 汽车金融行业面临着不断变化的客户期望、运营障碍和监管复杂性的挑战[5] - 公司利用数据、技术和人工智能的力量,为VWFS提供优化运营、提高客户满意度、降低风险和确保合规性的解决方案,最终推动VWFS的业务增长[5][6] 公司总结 - 公司拥有125,000多名员工,遍布30多个国家,致力于为客户创造持久价值[7] - 公司专注于数据、技术和人工智能,为金融服务行业提供深厚的行业知识和专业服务[5][7]

Collaboration to Leverage ImmunoForge's ELP Platform Technology Which Can Increase the Half-Life of a Drug by up to 200 Times CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has signed a joint research agreement, together with Dong-A ST Co. Ltd. and ImmunoForge, to develop a long-acting, once-monthly, formulation of DA-1726, a novel, dual oxyntomodulin ...

Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose prevented acute rejection and achieved >80% of the previous oral trough blood levels -- leading to diminished drug burden 9 out of 9 (100%) patients who completed the 12-week treatment chose to remain on TFF TAC by proceeding to the long-term extension Phase; 2 patients have been treated for over a year and 6 patients have been treated for more than 6 months Observed a 6.5-fold reduction in ...

Second quarter net income of $7.7 million Second quarter adjusted EBITDA of $25.8 million Dredging backlog of $807.9 million at June 30, 2024 HOUSTON, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the "Company") (Nasdaq: GLDD), the largest provider of dredging services in the United States, today reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenue was $170.1 million Total operating income was $14.6 million ...

ST. GALLEN, Switzerland, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ:SRAD) ("Sportradar" or the "Company"), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced that Craig Felenstein, the Company's Chief Financial Officer, will participate in Canaccord Genuity's 44th Annual Growth Conference on Wednesday August 14, 2024. The fireside chat will take place at 1:30 pm eastern time and will be webcast live at investor ...